1. Home
  2. DSX vs TRDA Comparison

DSX vs TRDA Comparison

Compare DSX & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$3.00

Market Cap

273.7M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.57

Market Cap

275.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
TRDA
Founded
1999
2016
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
275.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
DSX
TRDA
Price
$3.00
$6.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$21.00
AVG Volume (30 Days)
1.4M
264.4K
Earning Date
05-28-2026
05-08-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
$14.28
$39.97
Revenue Next Year
$4.87
$50.80
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$5.08
52 Week High
$3.20
$16.45

Technical Indicators

Market Signals
Indicator
DSX
TRDA
Relative Strength Index (RSI) 63.16 43.77
Support Level $2.29 $5.71
Resistance Level $3.09 $7.89
Average True Range (ATR) 0.11 0.42
MACD -0.01 -0.05
Stochastic Oscillator 58.00 26.60

Price Performance

Historical Comparison
DSX
TRDA

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: